Skip to content

The Effect of Lactation Cookies on Breastfeeding Outcomes in Lactating Women

The Effect of Lactation Cookies on Breastfeeding Outcomes: A Pilot Randomized-Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07030491
Enrollment
36
Registered
2025-06-22
Start date
2025-06-25
Completion date
2025-09-25
Last updated
2025-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding

Keywords

Lactation, Breastfeeding, Galactagogues, Milk production, Randomized controlled trial, Lactation cookies

Brief summary

The goal of this clinical trial is to learn if eating lactation cookies can help breastfeeding women make more milk. The main questions it aims to answer are: * Do lactation cookies help increase milk production? * Do lactation cookies make the breastfeeding experience easier or better? Researchers will compare lactation cookies to regular cookies to see if lactation cookies work better. Participants will: * Eat 2 cookies every day for 30 days * Visit the clinic 2 times, at the start and end of the study * Keep a simple record of their breastfeeding and cookie eating

Detailed description

Lactation cookies are popular among breastfeeding mothers because they often contain certain ingredients, such as fenugreek, ginger, and moringa, that are believed to help increase milk supply. Despite their widespread use, there is limited scientific evidence to confirm whether these cookies effectively increase breast milk volume or improve the breastfeeding experience. This randomized controlled trial aims to evaluate the effects of lactation cookies on milk production and breastfeeding outcomes among exclusively breastfeeding mothers. Participants will be randomly assigned to consume a total of 2 cookies per day for 30 days; the cookies will either be lactation cookies or control cookies lacking milk-enhancing ingredients. Breast milk volume will be measured at the beginning and end of the study using standardized collection methods. Additional data will be collected to assess breastfeeding experience and any changes in infant feeding patterns. This study will help clarify whether lactation cookies provide measurable benefits for breastfeeding mothers and their infants. The findings may support breastfeeding women and guide recommendations on the use of dietary galactagogues like lactation cookies.

Interventions

Participants will consume 2 cookies per day (approximately 40g daily) for 30 consecutive days. The lactation cookies contain ingredients commonly believed to enhance milk production, including moringa, fenugreek, and ginger.

Participants in the control group will consume 2 cookies per day (approximately 40g total) for 30 consecutive days. These cookies are matched in taste, appearance, and caloric content but do not contain any known galactagogue ingredients.

Sponsors

Keserwan Medical Center
CollaboratorOTHER
Little Melly
CollaboratorINDUSTRY
Notre Dame University - Louaize
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Participants will be randomly assigned to one of two groups (lactation cookies or control cookies) and will remain in their group for the 30-day intervention period.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Women 1 month postpartum * Exclusively breastfeeding * Aged 18-45 years * Healthy term infants (≥37 weeks gestation) * Uncomplicated pregnancies and births * Residing in Lebanon * Planning to exclusively breastfeed for at least 2 months * Intending to attend recommended pediatrician visits * Infants must be at least 1 month old

Exclusion criteria

* Twin pregnancy * Allergies or dislike of ingredients in the study cookies * Presence of any health condition including: thyroid disease, epilepsy, psychosis, or bipolar disorder * Currently receiving treatment for depression or anxiety * Mastitis * Smoking or alcohol consumption * Taking medications or substances that may affect milk production, including: metoclopramide, chlorpromazine, domperidone, herbal galactagogues, thyroid hormones, or blood thinning medications

Design outcomes

Primary

MeasureTime frameDescription
Change in breast milk volume from baseline to 1 month post-intervention1 monthBreast milk volume will be assessed using the 3-hour milk expression protocol developed by Lai et al. (2010). This method involves hourly milk expression sessions over a 3-hour period, during which milk synthesis reaches a steady state, allowing for accurate estimation of the milk production rate.

Secondary

MeasureTime frameDescription
Anxiety score changes from baseline to 1-month post intervention1 monthAssessed using the State-Trait Anxiety Inventory (STAI), which includes two 20-item scales (State and Trait anxiety) scored 20-80; higher scores indicate higher anxiety levels.
Changes in perceived milk supply scores from baseline to 1-month post intervention1 monthAssessed using the McCarter-Spaulding PIM questionnaire, with scores ranging from 5 to 50, where higher scores indicate greater perceived milk sufficiency.
Changes in postnatal depression scores from baseline to 1-month post intervention1 monthAssessed using the Edinburgh Postnatal Depression Scale (EPDS), a 10-item scale with scores ranging from 0 to 30; higher scores indicate more severe depressive symptoms. Scores ≥13 suggest possible depression
Change in infant weight from baseline to 1 month post-intervention1 monthInfant weight will be measured in kilograms (kg) using a calibrated infant scale by a pediatrician at baseline and after 1 month to assess changes in growth. Weight data will be interpreted using appropriate weight-for-age growth scores based on WHO growth standards.
Change in infant length from baseline to 1 month post-intervention1 monthInfant length will be measured in centimeters (cm) using an infantometer or measuring board by a pediatrician at baseline and after 1 month to assess changes in linear growth. Length data will be interpreted using appropriate length-for-age growth scores based on WHO growth standards.
Change in breastfeeding self-efficacy scores from baseline to 1 month post-intervention1 monthAssessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), a 14-item scale with scores ranging from 14 to 70, where higher scores indicate greater breastfeeding confidence.
Change in number of wet diapers from baseline to 1 month1 monthThe number of wet diapers per day will be recorded by the mother using self-reported logs throughout the 1-month intervention period to assess hydration status and feeding adequacy.
Change in number of soiled diapers from baseline to 1 month1 monthThe number of soiled diapers per day will be recorded by the mother using self-reported logs throughout the 1-month intervention period to assess digestive health and feeding adequacy.
Change in breast milk composition from baseline to 1 month post-intervention1 monthA 15 milliliter (mL) sample of breast milk will be collected from the mother at baseline and after 1 month to assess changes in milk composition. Analyses will focus on nutrient content and the potential transfer of bioactive components from the lactation cookies, including macronutrients (grams per liter, g/L), omega-3 fatty acids (milligrams per deciliter, mg/dL), and other relevant biomarkers.
Change in infant weight before and after each feed from baseline to 1 month post-intervention1 monthInfant weight will be measured in kilograms (kg) using a calibrated infant scale immediately before and after each feeding session at baseline and later on Day 30. The difference between pre- and post-feed weights will be calculated to estimate milk intake per feed.
Change in infant head circumference from baseline to 1 month post-intervention1 monthInfant head circumference will be measured in centimeters (cm) using a non-stretchable measuring tape by a pediatrician at baseline and after 1 month to assess brain growth and development. Head circumference data will be interpreted using appropriate head circumference-for-age growth scores based on WHO growth standards.

Countries

Lebanon

Contacts

Primary ContactJessy El Hayek, PhD
jelhayek@ndu.edu.lb+961 9 218 950
Backup ContactMaria Aoun, Msc
mmaoun02@ndu.edu.lb+961 70717124

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026